PTK2 and breast carcinoma: In agreement with a multifaceted action of FAK in the tumour stroma, myeloid cell-specific deletion of FAK in LysM-Cre mice with spontaneously developed mammary carcinomas was associated with both pro- and antitumorigenic functions depending on the stage of malignancy [29].